Please wait
SC 14A PREM14A EX-FILING FEES 0000882361 Aptose Biosciences Inc. N/A 0-11 0000882361 2025-11-28 2025-11-28 0000882361 1 2025-11-28 2025-11-28 iso4217:USD xbrli:pure xbrli:shares

Calculation of Filing Fee Tables

Table 1: Transaction Valuation

Proposed Maximum Aggregate Value of Transaction

Fee Rate

Amount of Filing Fee

Fees to be Paid 1 $ 3,508,318.05 0.0001381 $ 484.50
Fees Previously Paid

Total Transaction Valuation:

$ 3,508,318.05

Total Fees Due for Filing:

$ 484.50

Total Fees Previously Paid:

$ 0.00

Total Fee Offsets:

$ 0.00

Net Fee Due:

$ 484.50

Offering Note

1

(1) Estimated solely for purposes of calculating the filing fee, based on the cash consideration to be received by the registrant's shareholders in consideration for the transaction converted into United States dollars at an exchange rate of $0.71 per Cdn$1.00 Canadian dollar as computed in accordance with Rule 0-11 (Silcrow 240.0-11(c)(2)) of the Securities Exchange Act of 1934, as amended. (2) In accordance with Section 14(g) of the Exchange Act, the filing fee was calculated by multiplying the aggregate consideration to be received by the registrant determined as described in footnote (1) above by 0.00013810.

Table 2: Fee Offset Claims and Sources ☑Not Applicable
Registrant or Filer Name Form or Filing Type File Number Initial Filing Date Filing Date Fee Offset Claimed Fee Paid with Fee Offset Source
Fee Offset Claims N/A N/A N/A N/A N/A N/A N/A N/A
Fee Offset Sources N/A N/A N/A N/A N/A N/A N/A N/A